Am J Surg

1. DOURADO J, Bilotti M, Emile SH, Wignakumar A, et al
   Consistency of outcomes of studies on rectal cancer from the NCDB and SEER databases: A systematic review.
   Am J Surg. 2026;252:116728.
   

   >> Share

   
   
2. MONTGOMERY KB, Rademacher N, Richman JS, Bhatia S, et al
   Healthcare facility volume and evidence-based practice implementation in surgical care of patients with common cancers.
   Am J Surg. 2026;252:116733.
   

   >> Share

   
   

   
   Ann Surg

3. PU T, Gustafson A, Luberice K, Akmal SR, et al
   Underrepresentation of Racial and Ethnic Minorities in Metastatic Colorectal Carcinoma Clinical Trials Within the United States.
   Ann Surg. 2026;283:316-325.
   

   >> Share

   
   

   
   Ann Surg Oncol

4. AL MAHRIZI AD, Mossolem F
   ASO Author Reflections: Clinical Promise of Platinum Prophylactic Intraperitoneal Chemotherapy in Colorectal Cancer.
   Ann Surg Oncol. 2026 Jan 6. doi: 10.1245/s10434-025-19002.
   

   >> Share

   
   
5. BOND MJG, Bolhuis K, Linders TC, Mijnals C, et al
   ASO Visual Abstract: Prognostic Value of Circulating Tumor DNA for Recurrence and Survival in Patients Undergoing Local Treatment for Initially Unresectable RAS/RAF Mutated Colorectal Cancer Liver Metastases.
   Ann Surg Oncol. 2026 Jan 4. doi: 10.1245/s10434-025-18866.
   

   >> Share

   
   
6. HU Z, Tan K, Hu K, Xiao G, et al
   Non-steroidal Anti-inflammatory Drugs and Timing-specific Anastomotic Leak Risk Following Minimally Invasive Proctectomy: A Retrospective Cohort Study.
   Ann Surg Oncol. 2026;33:1270-1278.
   

   >> Share

   
   
7. CAI Z, Bai F, Liu X, Wang Z, et al
   Prognostic Value of Pathological Risk Parameters in Predicting Postrecurrent Survival for Locally Recurrent Rectal Cancer Patients Undergoing Salvage Radical Surgery: Result from a Median 5-year Follow-Up Study.
   Ann Surg Oncol. 2026;33:1260-1269.
   

   >> Share

   
   
8. CATS M, Magermans LG, Wassenaar ECE, van Geloven AAW, et al
   The Clinical Presentation of Anastomotic Leakage Compared Between CRS-HIPEC and Conventional Colorectal Surgery.
   Ann Surg Oncol. 2026;33:1706-1715.
   

   >> Share

   
   
9. MAINA C, Lopez-Lopez V, Ratti F, Santangelo D, et al
   Hepatic Hypertrophy Techniques: Comparing Perioperative Outcomes of Liver Venous Deprivation (LVD) and Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy-Variants (vALPPS) Among Two Referral Centers.
   Ann Surg Oncol. 2026;33:1503-1514.
   

   >> Share

   
   
10. ZAKI OA, Narayan RR, Srouji R, Boerner T, et al
    Hepatic Recurrence Rate Based on Extent of Adjuvant Floxuridine Exposure After Resection of Colorectal Liver Metastases.
    Ann Surg Oncol. 2026;33:1490-1502.
    

    >> Share

    
    
11. SAADAT LV, Goldman DA, Kalvin H, Gonen M, et al
    One-Year Mortality after Hepatectomy: Defining a Novel Quality Metric.
    Ann Surg Oncol. 2026;33:1481-1489.
    

    >> Share

    
    
12. BOILEVE A, Audemar F, Dupont-Bierre E, Le Sourd S, et al
    Treatment Intensification with Hepatic Arterial Infusion Chemotherapy in Patients with Liver-Only Colorectal Metastases Still Unresectable After Systemic Induction Chemotherapy: Exploratory Findings From a Prematurely Closed Multicenter Randomized Pha
    Ann Surg Oncol. 2026;33:1460-1469.
    

    >> Share

    
    
13. LI J, Waller G, Qin Y, Yu AT, et al
    Worse Survival in Co-Altered RAS-TP53 Patients With Resected Colorectal Liver Metastases.
    Ann Surg Oncol. 2026;33:1448-1459.
    

    >> Share

    
    

    
    BMC Cancer

14. KASSAW AB, Abera MB, Seid MA, Jemal M, et al
    KRAS mutation and its association with clinicopathological features of colorectal cancer patients in Africa: a systematic review and meta-analysis.
    BMC Cancer. 2026;26:31.
    

    >> Share

    
    
15. FAN S, Shao M, Ma W
    Association between serum uric acid levels and clinical outcomes of immunotherapy in advanced colorectal cancer patients.
    BMC Cancer. 2026 Jan 3. doi: 10.1186/s12885-025-15431.
    

    >> Share

    
    

    
    BMC Gastroenterol

16. DIERICK N, Lee C, Kostalas SN
    Benchmarking sessile serrated lesion detection in colonoscopy: individual endoscopist performance has greater impact than specialty training - a retrospective analysis of 12,064 procedures.
    BMC Gastroenterol. 2025;26:11.
    

    >> Share

    
    

    
    Br J Cancer

17. ZHANG X, Jin M, Chu Y, Liu F, et al
    STK32C activated IL-6/JAK2/STAT3 signaling and promoted tumor angiogenesis.
    Br J Cancer. 2026;134:60-71.
    

    >> Share

    
    
18. GWENZI T, Weber ANR, Trares K, Vlaski T, et al
    Effects of personalized vitamin D(3) on inflammation in colorectal cancer patients: a randomized trial.
    Br J Cancer. 2026 Jan 8. doi: 10.1038/s41416-025-03333.
    

    >> Share

    
    

    
    Br J Surg

19. RUBIO-ALARCON C, Georgiadis A, Franken IA, Wang H, et al
    Circulating tumour DNA in patients with stage III colon cancer: multicentre prospective PROVENC3 study.
    Br J Surg. 2025;113:znaf281.
    

    >> Share

    
    

    
    Cancer Lett

20. LIU C, Nie J, Li S, Ma S, et al
    Electroacupuncture Combined with Fruquintinib and Sintilimab in Microsatellite-Stable Metastatic Colorectal Cancer: A Phase II Study.
    Cancer Lett. 2026 Jan 2:218238. doi: 10.1016/j.canlet.2026.218238.
    

    >> Share

    
    

    
    Clin Cancer Res

21. KEYL J, Hosch R, Horst F, Keyl P, et al
    Deep Learning-derived Sarcopenia Marker Predicts Benefit from Anti-EGFR Therapy in Patients with RAS Wild-Type Metastatic Colorectal Cancer.
    Clin Cancer Res. 2026 Jan 5. doi: 10.1158/1078-0432.CCR-25-3080.
    

    >> Share

    
    

    
    Eur J Cancer

22. DARAI A, de Vries S, Beets GL, Nagtegaal ID, et al
    Trends in organ preservation in rectal cancer management: A population-based study in the Netherlands.
    Eur J Cancer. 2026;232:116154.
    

    >> Share

    
    
23. LUNENBERG RA, Franken IA, Braat MNGJA, Elferink MAG, et al
    The impact of mismatch repair status on accuracy of clinical staging in stage II/III rectal cancer in daily practice.
    Eur J Cancer. 2026;232:116117.
    

    >> Share

    
    

    
    Int J Colorectal Dis

24. LOSSIUS W, Stornes T, Myklebust TA, Wibe A, et al
    Consequences of omitting additional treatment after local excision of high-risk early rectal cancer: a national cohort.
    Int J Colorectal Dis. 2026;41:14.
    

    >> Share

    
    
25. TORRES-MARI N, Garcia-Fuster AG, Jeri-McFarlane S, Ochogavia-Segui A, et al
    Anatomy-guided computational framework for classifying vascular ligation and lymphadenectomy in oncologic sigmoidectomy: toward AI-supported surgical auditing.
    Int J Colorectal Dis. 2026;41:12.
    

    >> Share

    
    
26. SERRA-ARACIL X, Gener-Jorge C, Nonell A, Ferreres-Pinas JC, et al
    Long-term outcomes of pT1 rectal cancer after transanal endoscopic surgery: again, a word of caution on high local recurrence - a cohort study.
    Int J Colorectal Dis. 2026;41:10.
    

    >> Share

    
    
27. LIN S, Mao M, Chen R, Guo L, et al
    Gunsight closure versus conventional techniques for reversal of protective stoma after rectal cancer surgery: a propensity score matching study.
    Int J Colorectal Dis. 2026;41:15.
    

    >> Share

    
    
28. VAN ZON JFJA, Heijmans MHM, Bosch SL, Bloemen J, et al
    Histopathological assessment to detect colorectal ovarian micrometastasis following prophylactic salpingo-oophorectomy in postmenopausal patients.
    Int J Colorectal Dis. 2026;41:11.
    

    >> Share

    
    
29. QIU X, Kashchenko VA, Zavrazhnov AA, Lankov TS, et al
    Deep impact analysis of surgical strategy changes guided by indocyanine green fluorescence angiography in laparoscopic low anterior resection for rectal cancer.
    Int J Colorectal Dis. 2026;41:7.
    

    >> Share

    
    
30. ROSEN H, Sebesta CG, Sebesta M, Sebesta C, et al
    Living 20 years with perineal colostomy and dynamic graciloplasty - a case report discussing the role of this approach.
    Int J Colorectal Dis. 2026;41:9.
    

    >> Share

    
    
31. LAURIDSEN ED, Do Canto LM, Timm S, Havelund BM, et al
    Clinical utility of longitudinal ctDNA monitoring by multiplex MS-ddPCR for risk stratification and follow-up in rectal cancer.
    Int J Colorectal Dis. 2026;41:16.
    

    >> Share

    
    
32. BHATIA M, Kostadinov D
    Correspondence for the article titled - "Prognostic impact of metastatic sites and its metastasectomy in colorectal cancer: a retrospective analysis from a single institution".
    Int J Colorectal Dis. 2026;41:17.
    

    >> Share

    
    
33. CIVIL O, Sakoglu N, Tekin A, Kement M, et al
    Risk factors for non-reversal of diverting ileostomies: a retrospective analysis of 456 patients.
    Int J Colorectal Dis. 2026;41:21.
    

    >> Share

    
    
34. CHRISTODOULIS E, Ntellas P, Simpson L, Dadouli K, et al
    Exploring perceptual disparities: A study on the level of understanding of colorectal cancer care among patients and healthcare professionals.
    Int J Colorectal Dis. 2026;41:22.
    

    >> Share

    
    
35. DELORME M, Agger E, Jorgren F, Lydrup ML, et al
    Preoperative chemotherapy for colon cancer and short-term outcomes-a nationwide cohort study.
    Int J Colorectal Dis. 2026;41:23.
    

    >> Share

    
    
36. SUN Q, Sun R, He B, Meng H, et al
    The subtype identification of colorectal cancer and construction of the risk model based on cholesterol synthesis-related genes to predict prognosis and guide immunotherapy.
    Int J Colorectal Dis. 2026;41:24.
    

    >> Share

    
    
37. KONG Y, Wan L, Yue X, Tang F, et al
    An interpretable machine learning model based on MRI radiomics and GAME score for predicting early recurrence after thermal ablation in colorectal liver metastases.
    Int J Colorectal Dis. 2026;41:29.
    

    >> Share

    
    
38. WU J, Wu J, Zheng Z, Chen S, et al
    Machine learning-based integration of tumor deposit molecular signatures improves prognostic stratification in colon adenocarcinoma.
    Int J Colorectal Dis. 2026;41:28.
    

    >> Share

    
    
39. DING C, Yang J, Yang J, Zhou Y, et al
    Endoscopic submucosal dissection versus endoscopic mucosal resection for the treatment of rectal tumors extending to the dentate line: a systematic review and meta-analysis.
    Int J Colorectal Dis. 2026;41:26.
    

    >> Share

    
    

    
    J Clin Oncol

40. CONCA V, Rossini D, Antoniotti C, Lonardi S, et al
    Upfront Modified FOLFOXIRI Plus Panitumumab for RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Final Results of the Phase III TRIPLETE Study.
    J Clin Oncol. 2026 Jan 8:JCO2501337. doi: 10.1200/JCO-25-01337.
    

    >> Share

    
    
41. IVESON T, Saunders MP, Kelly C, Kerr RS, et al
    Three Versus 6 Months of Adjuvant Oxaliplatin-Fluoropyrimidine Chemotherapy for Colorectal Cancer: Final Results of SCOT-An International, Randomized, Phase III, Noninferiority Trial.
    J Clin Oncol. 2026 Jan 9:JCO2500621. doi: 10.1200/JCO-25-00621.
    

    >> Share

    
    

    
    J Natl Cancer Inst

42. SHAUKAT A, Meng Z, Kutnik K, Sun CK, et al
    Age- and sex-adjusted performance of a colorectal cancer screening test using US census distribution.
    J Natl Cancer Inst. 2026 Jan 9:djag007. doi: 10.1093.
    

    >> Share

    
    

    
    J Pathol

43. KOBA T, Hibiya T, Shibayama T, Kato K, et al
    Relative MYC downregulation and RUNX2 upregulation orchestrate partial epithelial-mesenchymal transition in colorectal cancer tumor budding and poorly differentiated clusters.
    J Pathol. 2026 Jan 9. doi: 10.1002/path.70013.
    

    >> Share

    
    

    
    PLoS One

44. DANTAS AAG, Oliveira NPD, Martins LFL, de Camargo Cancela M, et al
    Social determinants in the delay of starting colorectal cancer treatment.
    PLoS One. 2026;21:e0338727.
    

    >> Share

    
    
45. SCHOENAKER IJH, van Westreenen HL, Finnema EJ, Schrauwen R, et al
    Diagnostic performance of eNose technology in detecting colorectal cancer recurrence: A prospective evaluation.
    PLoS One. 2026;21:e0340276.
    

    >> Share

    
    
46. MECHLEB K, Hourani N, Fakhry M, Alyamani OA, et al
    Targeting ceramide metabolism to restore hypoxia-induced apoptosis in p53-deficient colon cancer cells.
    PLoS One. 2026;21:e0340295.
    

    >> Share

    
    
47. 
    Editorial Note: The multi-targeted kinase inhibitor sunitinib induces apoptosis in colon cancer cells via PUMA.
    PLoS One. 2026;21:e0339805.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share